Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells

Neurochemistry International

Volumn 61, Issue 6, 2012, Pages 923-930

  Juknat, Ana ^a   Rimmerman, Neta ^a,b   Levy, Rivka ^b   Vogel, Zvi ^a,b   Kozela, Ewa ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

9 Tetrahydrocannabinol; Cannabidiol; Matrix metalloproteinase 23; Metallothionein; Zinc transporters

Indexed keywords

CANNABIDIOL; DRONABINOL; HYDROLASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 23; MESSENGER RNA; METAL RESPONSIVE ELEMENT BINDING TRANSCRIPTION FACTOR 1; METALLOTHIONEIN II; N MYC DOWNSTREAM REGULATED GENE 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 472; ZINC TRANSPORTER; ZINC TRANSPORTER 1; ZINC TRANSPORTER 10; ZINC TRANSPORTER 4;

ANIMAL CELL; CONFERENCE PAPER; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; HOMEOSTASIS; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; CANNABIDIOL; CELL LINE; GENE EXPRESSION REGULATION; HOMEOSTASIS; MICROGLIA; ZINC;

EID: 84868198164     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.12.002     Document Type: Conference Paper

References (71)

1. G.K. Andrews Regulation of metallothionein gene expression by oxidative stress and metal ions Biochem. Pharmacol. 59 2000 95 104
2. M. Ashburner, C.A. Ball, J.A. Blake, D. Botstein, H. Butler, J.M. Cherry, A.P. Davis, K. Dolinski, S.S. Dwight, J.T. Eppig, M.A. Harris, D.P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J.C. Matese, J.E. Richardson, M. Ringwald, G.M. Rubin, and G. Sherlock Gene ontology: tool for the unification of biology Nat. Genet. 25 2000 25 29
3. M. Ashner The functional significance of brain metallothioneins FASEB J. 10 1996 1129 1136
4. G.A. Cabral, and D.A. Dove Pettit Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease J. Neuroimmunol. 83 1998 116 123
5. 2 in immune regulation: therapeutic prospects for neuroinflammation Expert Rev. 11 2009 e3
6. G.A. Cabral, and A. Staab Effects on the immune system Handb. Exp. Pharmacol. 168 2005 385 423
7. G.A. Cabral, E.S. Raborn, L. Griffin, J. Dennis, and F. Marciano-Cabral CB2 receptors in the brain: role in central immune function Br. J. Pharmacol. 153 2008 240 251
8. E.J. Carrier, J.A. Auchampach, and C.J. Hillard Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression Proc. Natl. Acad. Sci. USA 103 2006 7895 7900
9. J.L. Croxford, and T. Yamamura Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J. Neuroimmunol. 166 2005 3 18
10. L. De Petrocellis, and V. Di Marzo Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels J. Neuroimmune Pharmacol. 5 2010 103 121
11. M. Earleywine Understanding Marijuana: A New Look at the Scientific Evidence 2002 Oxford University Press
12. D.J. Eide Zinc transporters and the cellular trafficking of zinc Biochim. Biophys. Acta 1763 2006 711 722
13. I. Galve-Roperh, C. Sanchez, M.L. Cortes, T.G. del Pulgar, M. Izquierdo, and M. Guzman Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat. Med. 6 2000 313 319
14. M.B. Graeber, and W.J. Streit Microglia: biology and pathology Acta Neuropathol. 119 2010 89 105
15. H. Haase, and L. Rink Functional significance of zinc-related signaling pathways in immune cells Annu. Rev. Nutr. 29 2009 133 152
16. U.K. Hanisch, and H. Kettenmann Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nat. Neurosci. 10 2007 1387 1394
17. F. Haq, M. Mahoney, and J. Koropatnick Signaling events for metallothionein induction Mutat. Res. 533 2003 211 226
18. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
19. A.A. Izzo, F. Borrelli, R. Capasso, V. Di Marzo, and R. Mechoulam Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb Trends Pharmacol. Sci. 30 2009 515 527
20. K.A. Jackson, R.A. Valentine, L.J. Coneyworth, J.C. Mathers, and D. Ford Mechanisms of mammalian zinc-regulated gene expression Biochem. Soc. Trans. 36 2008 1262 1266
21. T.R. Jan, S.T. Su, H.Y. Wu, and M.H. Liao Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice Int. Immunopharmacol. 7 2007 773 780
22. 9- tetrahydrocannabinol in BV-2 microglial cells. Br. J. Pharmacol. doi:10.1111/j.1476-5381.2011.01461.x.
23. B.L. Kaplan, C.E. Rockwell, and N.E. Kaminski Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes J. Pharmacol. Exp. Ther. 306 2003 1077 1085
24. B. Kindermann, F. Doering, D. Fuchs, M.W. Pfaffl, and H. Daniel Effects of increased cellular zinc levels on gene and protein expression in HT-29 cells BioMetals 18 2005 243 253
25. T.W. Klein, and G.A. Cabral Cannabinoid-induced immune suppression and modulation of antigen-presenting cells J. Neuroimmune Pharmacol. 1 2006 50 64
26. T.W. Klein, C. Newton, and H. Friedman Cannabinoid receptors and immunity Immunol. Today 19 1998 373 381
27. T.W. Klein, C. Newton, K. Larsen, J. Chou, I. Perkins, L. Lu, L. Nong, and H. Friedman Cannabinoid receptors and T helper cells J. Neuroimmunol. 147 2004 91 94
28. N.M. Kogan, and R. Mechoulam Cannabinoids in health and disease Dialogues Clin. Neurosci. 9 2007 413 430
29. 9-tetrahydrocannabinol and cannabidiol differentially inhibit the LPS-activated NF-κB and IFNβ/STAT proinflammatory pathways in BV-2 microglial cells J. Biol. Chem. 285 2010 1616 1625
30. E. Kozela, N. Lev, N. Kaushansky, R. Eilam, N. Rimmerman, R. Levy, A. Ben-Nun, A. Juknat, and Z. Vogel Cannabidiol inhibits pathogenic T-cells, decreased spinal microglial activation and ameliorates multiple sclerosis-like disease in mice Br. J. Pharmacol. 163 2011 1507 1519
31. J.H. Laity, and G.K. Andrews Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1) Arch. Biochem. Biophys. 463 2007 201 210
32. 1 receptor antagonists as promising new medications for drug dependence J. Pharmacol. Exp. Ther. 312 2005 875 883
33. P. Lichten, Y. Wang, T. Belser, O. Georgiev, U. Certa, R. Sack, and W. Schaffner Target gene search for the metal-responsive transcription factor MTF-1 Nucleic Acids Res. 29 2001 1514 1523
34. D.Z. Liu, C.M. Hu, C.H. Huang, S.P. Wey, and T.R. Jan Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity Acta Pharmacol. Sin. 31 2010 1611 1617
35. R.S. MacDonald The role of zinc in growth and cell proliferation J. Nutr. 130 2000 1500S 1508S
36. A.M. Manicone, and J.K. McGuire Matrix metalloproteinases as modulators of inflammation Semin. Cell Dev. Biol. 19 2008 34 41
37. P. Massi, A. Vaccani, S. Bianchessi, B. Costa, P. Macchi, and D. Parolaro The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells Cell. Mol. Life Sci. 63 2006 2057 2066
38. R.J. McKallip, C. Lombard, B.R. Martin, M. Nagarkatti, and P.S. Nagarkatti Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo J. Pharmacol. Exp. Ther. 302 2002 451 465
39. R. Mechoulam, L.A. Parker, and R. Gallily Cannabidiol: an overview of some pharmacological aspects J. Clin. Pharmacol. 42 2002 11S 19S
40. R. Mechoulam, M. Peters, E. Murillo-Rodriguez, and L.O. Hanus Cannabidiol-recent advances Chem. Biodiversity 4 2007 1678 1692
41. V. Melote, X. Qu, M. Ongenaert, W. van Criekinge, A.P. de Bruine, H. Scott Baldwin, and M. van Engeland The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications FASEB J. 24 2010 4153 4166
42. R.M. Murray, P.D. Morrison, C. Henquet, and M. Di Forti Cannabis, the mind and society: the hash realities Nat. Rev. Neurosci. 8 2007 885 895
43. G.G. Nahas, N. Suciu-Foca, J.P. Armand, and A. Morishima Inhibition of cellular mediated immunity in marihuana smokers Science 183 1974 419 420
44. C. Nolte, A. Gore, I. Sekler, W. Kresse, M. Hershfinkel, A. Hoffmann, H. Kettenmann, and A. Moran ZnT-1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc Glia 48 2004 145 155
45. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 152 2007 576 582
46. D. Pei CA-MMP: a matrix metalloproteinase with a novel cysteine array, but without the classic cysteine switch FEBS Lett. 457 1999 262 270
47. D. Pei, T. Kang, and H. Qi Cysteine Array Matrix Metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation J. Biol. Chem. 275 2000 33988 33997
48. M. Penkowa Metallothioneins are multipurpose neuroprotectans during brain pathology FEBS J. 273 2006 1857 1870
49. M. Penkowa, and J. Hidalgo Metallothionein I and II expression and their role in experimental autoimmune encephalomyelitis Glia 32 2000 247 263
50. M. Penkowa, and J. Hidalgo Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-α and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE) Exp. Neurol. 170 2001 1 14
51. R.G. Pertwee Pharmacological actions of cannabinoids Handb. Exp. Pharmacol. 168 2005 1 51
52. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 156 2009 397 411
53. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, and R.A. Ross International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol. Rev. 62 2010 588 631
54. M. Pietr, E. Kozela, R. Levy, N. Rimmerman, Y.H. Lin, N. Stella, Z. Vogel, and A. Juknat Differential changes in GPR55 during microglial activation FEBS Lett. 583 2009 2071 2076
55. A.S. Prasad Zinc in human health: effect of zinc on immune cells Mol. Med. 14 2008 353 357
56. A.S. Prasad Zinc: role in immunity, oxidative stress and chronic inflammation Curr. Opin. Clin. Nutr. Metab. Care 12 2009 646 652
57. M.H. Rhee, Z. Vogel, J. Barg, M. Bayewitch, R. Levy, L. Hanus, A. Breuer, and R. Mechoulam Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase J. Med. Chem. 40 1997 3228 3233
58. S.A. Rieder, A. Chauhan, U. Singh, M. Nagarkatti, and P. Nagarkatti Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression Immunobiology 215 2010 598 605
59. N. Rimmerman, A. Juknat, E. Kozela, R. Levy, H.B. Bradshaw, and Z. Vogel The non-psychoactive plant cannabinoid, cannabidiol, affects cholesterol metabolism-related genes in microglial cells Cell. Mol. Neurobiol. 31 2011 921 930
60. G.A. Rosenberg Matrix metalloproteinases and their multiple roles in neurodegenerative diseases Lancet Neurol. 8 2009 205 216
61. C. Scuderi, D.D. Filippis, T. Iuvone, A. Blasio, A. Steardo, and G. Esposito Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders Phytother. Res. 23 2009 597 602
62. S.L. Sensi, P. Paoletti, A.I. Bush, and I. Sekler Zinc in the physiology and pathology of the CNS Nat. Rev. Neurosci. 10 2009 780 791
63. 2+-induced cell death is mediated by the induction of intracellular ROS in ARPE-19 cells Curr. Eye Res. 28 2004 195 201
64. 9- Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacology 40 1998 179 185
65. N. Stella Cannabinoid and cannabinoid-like receptors in microglia, astrocytes and astrocytomas Glia 58 2010 1017 1030
66. W.J. Streit Microglia and neuroprotection: implications for Alzheimer's disease Brain Res. Brain Res. Rev. 48 2005 234 239
67. M. van der Stelt, and V. Di Marzo Cannabinoid receptors and their role in neuroprotection Neuromol. Med. 7 2005 37 50
68. P. Van Lint, and C. Libert Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation J. Leukoc. Biol. 82 2007 1375 1381
69. L. Walter, and N. Stella Cannabinoids and neuroinflammation Br. J. Pharmacol. 141 2004 775 785
70. U. Wimmer, Y. Wang, O. Georgiev, and W. Schaffner Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione Nucleic Acids Res. 33 2005 5715 5727
71. K. Woelkart, O.M. Salo-Ahen, and R. Bauer CB receptor ligands from plants Curr. Top. Med. Chem. 8 2008 173 186